0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Melatonin Receptor Agonists Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-12L14987
Home | Market Reports | Health| Health Conditions| Sleep Disorders
Global Melatonin Receptor Agonists Market Research Report 2023
BUY CHAPTERS

Global Melatonin Receptor Agonists Market Research Report 2025

Code: QYRE-Auto-12L14987
Report
May 2025
Pages:97
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Melatonin Receptor Agonists Market Size

The global market for Melatonin Receptor Agonists was valued at US$ 278 million in the year 2024 and is projected to reach a revised size of US$ 537 million by 2031, growing at a CAGR of 10.0% during the forecast period.

Melatonin Receptor Agonists Market

Melatonin Receptor Agonists Market

Melatonin receptor agonists, also known as melatonin agonists or melatonergic drugs, are a class of medications that bind and activate melatonin receptors in the brain. These receptors play a crucial role in regulating the sleep-wake cycle and circadian rhythms.
The market for melatonin receptor agonists has witnessed growth in recent years due to the increasing recognition of the importance of sleep health and the rising prevalence of sleep disorders worldwide. Factors contributing to the market growth include lifestyle changes, stress-related sleep disturbances, shift work, and the growing elderly population, as sleep disorders tend to be more common in older adults.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Melatonin Receptor Agonists, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Melatonin Receptor Agonists.
The Melatonin Receptor Agonists market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Melatonin Receptor Agonists market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Melatonin Receptor Agonists manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Melatonin Receptor Agonists Market Report

Report Metric Details
Report Name Melatonin Receptor Agonists Market
Accounted market size in year US$ 278 million
Forecasted market size in 2031 US$ 537 million
CAGR 10.0%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Ramelteon
  • Tasimelteon
  • Agomelatine
  • Other
Segment by Application
  • Hospital
  • Clinic
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Takeda Pharmaceutical, Vanda Pharmaceuticals, Pfizer, Natrol, Pharmavite, Nature's Bounty, Jameison, Rexall Sundown, GNC, Xiu Zheng, Church & Dwight, BY-HEALTH, Solgar, Biotics Research, Now Food
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Melatonin Receptor Agonists manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Melatonin Receptor Agonists in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Melatonin Receptor Agonists Market growing?

Ans: The Melatonin Receptor Agonists Market witnessing a CAGR of 10.0% during the forecast period 2025-2031.

What is the Melatonin Receptor Agonists Market size in 2031?

Ans: The Melatonin Receptor Agonists Market size in 2031 will be US$ 537 million.

Who are the main players in the Melatonin Receptor Agonists Market report?

Ans: The main players in the Melatonin Receptor Agonists Market are Takeda Pharmaceutical, Vanda Pharmaceuticals, Pfizer, Natrol, Pharmavite, Nature's Bounty, Jameison, Rexall Sundown, GNC, Xiu Zheng, Church & Dwight, BY-HEALTH, Solgar, Biotics Research, Now Food

What are the Application segmentation covered in the Melatonin Receptor Agonists Market report?

Ans: The Applications covered in the Melatonin Receptor Agonists Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Melatonin Receptor Agonists Market report?

Ans: The Types covered in the Melatonin Receptor Agonists Market report are Ramelteon, Tasimelteon, Agomelatine, Other

1 Melatonin Receptor Agonists Market Overview
1.1 Product Definition
1.2 Melatonin Receptor Agonists by Type
1.2.1 Global Melatonin Receptor Agonists Market Value Comparison by Type (2024 VS 2031)
1.2.2 Ramelteon
1.2.3 Tasimelteon
1.2.4 Agomelatine
1.2.5 Other
1.3 Melatonin Receptor Agonists by Application
1.3.1 Global Melatonin Receptor Agonists Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Melatonin Receptor Agonists Market Size Estimates and Forecasts
1.4.1 Global Melatonin Receptor Agonists Revenue 2020-2031
1.4.2 Global Melatonin Receptor Agonists Sales 2020-2031
1.4.3 Global Melatonin Receptor Agonists Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Melatonin Receptor Agonists Market Competition by Manufacturers
2.1 Global Melatonin Receptor Agonists Sales Market Share by Manufacturers (2020-2025)
2.2 Global Melatonin Receptor Agonists Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Melatonin Receptor Agonists Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Melatonin Receptor Agonists, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Melatonin Receptor Agonists, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Melatonin Receptor Agonists, Product Type & Application
2.7 Global Key Manufacturers of Melatonin Receptor Agonists, Date of Enter into This Industry
2.8 Global Melatonin Receptor Agonists Market Competitive Situation and Trends
2.8.1 Global Melatonin Receptor Agonists Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Melatonin Receptor Agonists Players Market Share by Revenue
2.8.3 Global Melatonin Receptor Agonists Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Melatonin Receptor Agonists Market Scenario by Region
3.1 Global Melatonin Receptor Agonists Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Melatonin Receptor Agonists Sales by Region: 2020-2031
3.2.1 Global Melatonin Receptor Agonists Sales by Region: 2020-2025
3.2.2 Global Melatonin Receptor Agonists Sales by Region: 2026-2031
3.3 Global Melatonin Receptor Agonists Revenue by Region: 2020-2031
3.3.1 Global Melatonin Receptor Agonists Revenue by Region: 2020-2025
3.3.2 Global Melatonin Receptor Agonists Revenue by Region: 2026-2031
3.4 North America Melatonin Receptor Agonists Market Facts & Figures by Country
3.4.1 North America Melatonin Receptor Agonists Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Melatonin Receptor Agonists Sales by Country (2020-2031)
3.4.3 North America Melatonin Receptor Agonists Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Melatonin Receptor Agonists Market Facts & Figures by Country
3.5.1 Europe Melatonin Receptor Agonists Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Melatonin Receptor Agonists Sales by Country (2020-2031)
3.5.3 Europe Melatonin Receptor Agonists Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Melatonin Receptor Agonists Market Facts & Figures by Region
3.6.1 Asia Pacific Melatonin Receptor Agonists Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Melatonin Receptor Agonists Sales by Region (2020-2031)
3.6.3 Asia Pacific Melatonin Receptor Agonists Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Melatonin Receptor Agonists Market Facts & Figures by Country
3.7.1 Latin America Melatonin Receptor Agonists Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Melatonin Receptor Agonists Sales by Country (2020-2031)
3.7.3 Latin America Melatonin Receptor Agonists Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Melatonin Receptor Agonists Market Facts & Figures by Country
3.8.1 Middle East and Africa Melatonin Receptor Agonists Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Melatonin Receptor Agonists Sales by Country (2020-2031)
3.8.3 Middle East and Africa Melatonin Receptor Agonists Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Melatonin Receptor Agonists Sales by Type (2020-2031)
4.1.1 Global Melatonin Receptor Agonists Sales by Type (2020-2025)
4.1.2 Global Melatonin Receptor Agonists Sales by Type (2026-2031)
4.1.3 Global Melatonin Receptor Agonists Sales Market Share by Type (2020-2031)
4.2 Global Melatonin Receptor Agonists Revenue by Type (2020-2031)
4.2.1 Global Melatonin Receptor Agonists Revenue by Type (2020-2025)
4.2.2 Global Melatonin Receptor Agonists Revenue by Type (2026-2031)
4.2.3 Global Melatonin Receptor Agonists Revenue Market Share by Type (2020-2031)
4.3 Global Melatonin Receptor Agonists Price by Type (2020-2031)
5 Segment by Application
5.1 Global Melatonin Receptor Agonists Sales by Application (2020-2031)
5.1.1 Global Melatonin Receptor Agonists Sales by Application (2020-2025)
5.1.2 Global Melatonin Receptor Agonists Sales by Application (2026-2031)
5.1.3 Global Melatonin Receptor Agonists Sales Market Share by Application (2020-2031)
5.2 Global Melatonin Receptor Agonists Revenue by Application (2020-2031)
5.2.1 Global Melatonin Receptor Agonists Revenue by Application (2020-2025)
5.2.2 Global Melatonin Receptor Agonists Revenue by Application (2026-2031)
5.2.3 Global Melatonin Receptor Agonists Revenue Market Share by Application (2020-2031)
5.3 Global Melatonin Receptor Agonists Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Takeda Pharmaceutical
6.1.1 Takeda Pharmaceutical Company Information
6.1.2 Takeda Pharmaceutical Description and Business Overview
6.1.3 Takeda Pharmaceutical Melatonin Receptor Agonists Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Takeda Pharmaceutical Melatonin Receptor Agonists Product Portfolio
6.1.5 Takeda Pharmaceutical Recent Developments/Updates
6.2 Vanda Pharmaceuticals
6.2.1 Vanda Pharmaceuticals Company Information
6.2.2 Vanda Pharmaceuticals Description and Business Overview
6.2.3 Vanda Pharmaceuticals Melatonin Receptor Agonists Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Vanda Pharmaceuticals Melatonin Receptor Agonists Product Portfolio
6.2.5 Vanda Pharmaceuticals Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Company Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Melatonin Receptor Agonists Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Pfizer Melatonin Receptor Agonists Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 Natrol
6.4.1 Natrol Company Information
6.4.2 Natrol Description and Business Overview
6.4.3 Natrol Melatonin Receptor Agonists Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Natrol Melatonin Receptor Agonists Product Portfolio
6.4.5 Natrol Recent Developments/Updates
6.5 Pharmavite
6.5.1 Pharmavite Company Information
6.5.2 Pharmavite Description and Business Overview
6.5.3 Pharmavite Melatonin Receptor Agonists Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Pharmavite Melatonin Receptor Agonists Product Portfolio
6.5.5 Pharmavite Recent Developments/Updates
6.6 Nature's Bounty
6.6.1 Nature's Bounty Company Information
6.6.2 Nature's Bounty Description and Business Overview
6.6.3 Nature's Bounty Melatonin Receptor Agonists Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Nature's Bounty Melatonin Receptor Agonists Product Portfolio
6.6.5 Nature's Bounty Recent Developments/Updates
6.7 Jameison
6.7.1 Jameison Company Information
6.7.2 Jameison Description and Business Overview
6.7.3 Jameison Melatonin Receptor Agonists Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Jameison Melatonin Receptor Agonists Product Portfolio
6.7.5 Jameison Recent Developments/Updates
6.8 Rexall Sundown
6.8.1 Rexall Sundown Company Information
6.8.2 Rexall Sundown Description and Business Overview
6.8.3 Rexall Sundown Melatonin Receptor Agonists Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Rexall Sundown Melatonin Receptor Agonists Product Portfolio
6.8.5 Rexall Sundown Recent Developments/Updates
6.9 GNC
6.9.1 GNC Company Information
6.9.2 GNC Description and Business Overview
6.9.3 GNC Melatonin Receptor Agonists Sales, Revenue and Gross Margin (2020-2025)
6.9.4 GNC Melatonin Receptor Agonists Product Portfolio
6.9.5 GNC Recent Developments/Updates
6.10 Xiu Zheng
6.10.1 Xiu Zheng Company Information
6.10.2 Xiu Zheng Description and Business Overview
6.10.3 Xiu Zheng Melatonin Receptor Agonists Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Xiu Zheng Melatonin Receptor Agonists Product Portfolio
6.10.5 Xiu Zheng Recent Developments/Updates
6.11 Church & Dwight
6.11.1 Church & Dwight Company Information
6.11.2 Church & Dwight Description and Business Overview
6.11.3 Church & Dwight Melatonin Receptor Agonists Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Church & Dwight Melatonin Receptor Agonists Product Portfolio
6.11.5 Church & Dwight Recent Developments/Updates
6.12 BY-HEALTH
6.12.1 BY-HEALTH Company Information
6.12.2 BY-HEALTH Description and Business Overview
6.12.3 BY-HEALTH Melatonin Receptor Agonists Sales, Revenue and Gross Margin (2020-2025)
6.12.4 BY-HEALTH Melatonin Receptor Agonists Product Portfolio
6.12.5 BY-HEALTH Recent Developments/Updates
6.13 Solgar
6.13.1 Solgar Company Information
6.13.2 Solgar Description and Business Overview
6.13.3 Solgar Melatonin Receptor Agonists Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Solgar Melatonin Receptor Agonists Product Portfolio
6.13.5 Solgar Recent Developments/Updates
6.14 Biotics Research
6.14.1 Biotics Research Company Information
6.14.2 Biotics Research Description and Business Overview
6.14.3 Biotics Research Melatonin Receptor Agonists Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Biotics Research Melatonin Receptor Agonists Product Portfolio
6.14.5 Biotics Research Recent Developments/Updates
6.15 Now Food
6.15.1 Now Food Company Information
6.15.2 Now Food Description and Business Overview
6.15.3 Now Food Melatonin Receptor Agonists Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Now Food Melatonin Receptor Agonists Product Portfolio
6.15.5 Now Food Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Melatonin Receptor Agonists Industry Chain Analysis
7.2 Melatonin Receptor Agonists Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Melatonin Receptor Agonists Production Mode & Process Analysis
7.4 Melatonin Receptor Agonists Sales and Marketing
7.4.1 Melatonin Receptor Agonists Sales Channels
7.4.2 Melatonin Receptor Agonists Distributors
7.5 Melatonin Receptor Agonists Customer Analysis
8 Melatonin Receptor Agonists Market Dynamics
8.1 Melatonin Receptor Agonists Industry Trends
8.2 Melatonin Receptor Agonists Market Drivers
8.3 Melatonin Receptor Agonists Market Challenges
8.4 Melatonin Receptor Agonists Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Melatonin Receptor Agonists Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Melatonin Receptor Agonists Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Melatonin Receptor Agonists Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Melatonin Receptor Agonists Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Melatonin Receptor Agonists Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Melatonin Receptor Agonists Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Melatonin Receptor Agonists Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Melatonin Receptor Agonists Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Melatonin Receptor Agonists, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Melatonin Receptor Agonists, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Melatonin Receptor Agonists, Product Type & Application
 Table 12. Global Key Manufacturers of Melatonin Receptor Agonists, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Melatonin Receptor Agonists by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Melatonin Receptor Agonists as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Melatonin Receptor Agonists Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Melatonin Receptor Agonists Sales by Region (2020-2025) & (K Units)
 Table 18. Global Melatonin Receptor Agonists Sales Market Share by Region (2020-2025)
 Table 19. Global Melatonin Receptor Agonists Sales by Region (2026-2031) & (K Units)
 Table 20. Global Melatonin Receptor Agonists Sales Market Share by Region (2026-2031)
 Table 21. Global Melatonin Receptor Agonists Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Melatonin Receptor Agonists Revenue Market Share by Region (2020-2025)
 Table 23. Global Melatonin Receptor Agonists Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Melatonin Receptor Agonists Revenue Market Share by Region (2026-2031)
 Table 25. North America Melatonin Receptor Agonists Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Melatonin Receptor Agonists Sales by Country (2020-2025) & (K Units)
 Table 27. North America Melatonin Receptor Agonists Sales by Country (2026-2031) & (K Units)
 Table 28. North America Melatonin Receptor Agonists Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Melatonin Receptor Agonists Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Melatonin Receptor Agonists Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Melatonin Receptor Agonists Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Melatonin Receptor Agonists Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Melatonin Receptor Agonists Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Melatonin Receptor Agonists Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Melatonin Receptor Agonists Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Melatonin Receptor Agonists Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Melatonin Receptor Agonists Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Melatonin Receptor Agonists Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Melatonin Receptor Agonists Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Melatonin Receptor Agonists Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Melatonin Receptor Agonists Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Melatonin Receptor Agonists Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Melatonin Receptor Agonists Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Melatonin Receptor Agonists Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Melatonin Receptor Agonists Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Melatonin Receptor Agonists Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Melatonin Receptor Agonists Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Melatonin Receptor Agonists Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Melatonin Receptor Agonists Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Melatonin Receptor Agonists Sales (K Units) by Type (2020-2025)
 Table 51. Global Melatonin Receptor Agonists Sales (K Units) by Type (2026-2031)
 Table 52. Global Melatonin Receptor Agonists Sales Market Share by Type (2020-2025)
 Table 53. Global Melatonin Receptor Agonists Sales Market Share by Type (2026-2031)
 Table 54. Global Melatonin Receptor Agonists Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Melatonin Receptor Agonists Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Melatonin Receptor Agonists Revenue Market Share by Type (2020-2025)
 Table 57. Global Melatonin Receptor Agonists Revenue Market Share by Type (2026-2031)
 Table 58. Global Melatonin Receptor Agonists Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Melatonin Receptor Agonists Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Melatonin Receptor Agonists Sales (K Units) by Application (2020-2025)
 Table 61. Global Melatonin Receptor Agonists Sales (K Units) by Application (2026-2031)
 Table 62. Global Melatonin Receptor Agonists Sales Market Share by Application (2020-2025)
 Table 63. Global Melatonin Receptor Agonists Sales Market Share by Application (2026-2031)
 Table 64. Global Melatonin Receptor Agonists Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Melatonin Receptor Agonists Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Melatonin Receptor Agonists Revenue Market Share by Application (2020-2025)
 Table 67. Global Melatonin Receptor Agonists Revenue Market Share by Application (2026-2031)
 Table 68. Global Melatonin Receptor Agonists Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Melatonin Receptor Agonists Price (US$/Unit) by Application (2026-2031)
 Table 70. Takeda Pharmaceutical Company Information
 Table 71. Takeda Pharmaceutical Description and Business Overview
 Table 72. Takeda Pharmaceutical Melatonin Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Takeda Pharmaceutical Melatonin Receptor Agonists Product
 Table 74. Takeda Pharmaceutical Recent Developments/Updates
 Table 75. Vanda Pharmaceuticals Company Information
 Table 76. Vanda Pharmaceuticals Description and Business Overview
 Table 77. Vanda Pharmaceuticals Melatonin Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Vanda Pharmaceuticals Melatonin Receptor Agonists Product
 Table 79. Vanda Pharmaceuticals Recent Developments/Updates
 Table 80. Pfizer Company Information
 Table 81. Pfizer Description and Business Overview
 Table 82. Pfizer Melatonin Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Pfizer Melatonin Receptor Agonists Product
 Table 84. Pfizer Recent Developments/Updates
 Table 85. Natrol Company Information
 Table 86. Natrol Description and Business Overview
 Table 87. Natrol Melatonin Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Natrol Melatonin Receptor Agonists Product
 Table 89. Natrol Recent Developments/Updates
 Table 90. Pharmavite Company Information
 Table 91. Pharmavite Description and Business Overview
 Table 92. Pharmavite Melatonin Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Pharmavite Melatonin Receptor Agonists Product
 Table 94. Pharmavite Recent Developments/Updates
 Table 95. Nature's Bounty Company Information
 Table 96. Nature's Bounty Description and Business Overview
 Table 97. Nature's Bounty Melatonin Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Nature's Bounty Melatonin Receptor Agonists Product
 Table 99. Nature's Bounty Recent Developments/Updates
 Table 100. Jameison Company Information
 Table 101. Jameison Description and Business Overview
 Table 102. Jameison Melatonin Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Jameison Melatonin Receptor Agonists Product
 Table 104. Jameison Recent Developments/Updates
 Table 105. Rexall Sundown Company Information
 Table 106. Rexall Sundown Description and Business Overview
 Table 107. Rexall Sundown Melatonin Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Rexall Sundown Melatonin Receptor Agonists Product
 Table 109. Rexall Sundown Recent Developments/Updates
 Table 110. GNC Company Information
 Table 111. GNC Description and Business Overview
 Table 112. GNC Melatonin Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. GNC Melatonin Receptor Agonists Product
 Table 114. GNC Recent Developments/Updates
 Table 115. Xiu Zheng Company Information
 Table 116. Xiu Zheng Description and Business Overview
 Table 117. Xiu Zheng Melatonin Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Xiu Zheng Melatonin Receptor Agonists Product
 Table 119. Xiu Zheng Recent Developments/Updates
 Table 120. Church & Dwight Company Information
 Table 121. Church & Dwight Description and Business Overview
 Table 122. Church & Dwight Melatonin Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Church & Dwight Melatonin Receptor Agonists Product
 Table 124. Church & Dwight Recent Developments/Updates
 Table 125. BY-HEALTH Company Information
 Table 126. BY-HEALTH Description and Business Overview
 Table 127. BY-HEALTH Melatonin Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. BY-HEALTH Melatonin Receptor Agonists Product
 Table 129. BY-HEALTH Recent Developments/Updates
 Table 130. Solgar Company Information
 Table 131. Solgar Description and Business Overview
 Table 132. Solgar Melatonin Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Solgar Melatonin Receptor Agonists Product
 Table 134. Solgar Recent Developments/Updates
 Table 135. Biotics Research Company Information
 Table 136. Biotics Research Description and Business Overview
 Table 137. Biotics Research Melatonin Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Biotics Research Melatonin Receptor Agonists Product
 Table 139. Biotics Research Recent Developments/Updates
 Table 140. Now Food Company Information
 Table 141. Now Food Description and Business Overview
 Table 142. Now Food Melatonin Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Now Food Melatonin Receptor Agonists Product
 Table 144. Now Food Recent Developments/Updates
 Table 145. Key Raw Materials Lists
 Table 146. Raw Materials Key Suppliers Lists
 Table 147. Melatonin Receptor Agonists Distributors List
 Table 148. Melatonin Receptor Agonists Customers List
 Table 149. Melatonin Receptor Agonists Market Trends
 Table 150. Melatonin Receptor Agonists Market Drivers
 Table 151. Melatonin Receptor Agonists Market Challenges
 Table 152. Melatonin Receptor Agonists Market Restraints
 Table 153. Research Programs/Design for This Report
 Table 154. Key Data Information from Secondary Sources
 Table 155. Key Data Information from Primary Sources
 Table 156. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Melatonin Receptor Agonists
 Figure 2. Global Melatonin Receptor Agonists Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Melatonin Receptor Agonists Market Share by Type: 2024 & 2031
 Figure 4. Ramelteon Product Picture
 Figure 5. Tasimelteon Product Picture
 Figure 6. Agomelatine Product Picture
 Figure 7. Other Product Picture
 Figure 8. Global Melatonin Receptor Agonists Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Melatonin Receptor Agonists Market Share by Application: 2024 & 2031
 Figure 10. Hospital
 Figure 11. Clinic
 Figure 12. Other
 Figure 13. Global Melatonin Receptor Agonists Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Melatonin Receptor Agonists Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Melatonin Receptor Agonists Sales (2020-2031) & (K Units)
 Figure 16. Global Melatonin Receptor Agonists Average Price (US$/Unit) & (2020-2031)
 Figure 17. Melatonin Receptor Agonists Report Years Considered
 Figure 18. Melatonin Receptor Agonists Sales Share by Manufacturers in 2024
 Figure 19. Global Melatonin Receptor Agonists Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Melatonin Receptor Agonists Players: Market Share by Revenue in Melatonin Receptor Agonists in 2024
 Figure 21. Melatonin Receptor Agonists Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Melatonin Receptor Agonists Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Melatonin Receptor Agonists Sales Market Share by Country (2020-2031)
 Figure 24. North America Melatonin Receptor Agonists Revenue Market Share by Country (2020-2031)
 Figure 25. United States Melatonin Receptor Agonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Melatonin Receptor Agonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Melatonin Receptor Agonists Sales Market Share by Country (2020-2031)
 Figure 28. Europe Melatonin Receptor Agonists Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Melatonin Receptor Agonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Melatonin Receptor Agonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Melatonin Receptor Agonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Melatonin Receptor Agonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Melatonin Receptor Agonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Melatonin Receptor Agonists Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Melatonin Receptor Agonists Revenue Market Share by Region (2020-2031)
 Figure 36. China Melatonin Receptor Agonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Melatonin Receptor Agonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Melatonin Receptor Agonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Melatonin Receptor Agonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Melatonin Receptor Agonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. China Taiwan Melatonin Receptor Agonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Southeast Asia Melatonin Receptor Agonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Melatonin Receptor Agonists Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Melatonin Receptor Agonists Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Melatonin Receptor Agonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Melatonin Receptor Agonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Melatonin Receptor Agonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Melatonin Receptor Agonists Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Melatonin Receptor Agonists Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Melatonin Receptor Agonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Melatonin Receptor Agonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE Melatonin Receptor Agonists Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Melatonin Receptor Agonists by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Melatonin Receptor Agonists by Type (2020-2031)
 Figure 55. Global Melatonin Receptor Agonists Price (US$/Unit) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Melatonin Receptor Agonists by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Melatonin Receptor Agonists by Application (2020-2031)
 Figure 58. Global Melatonin Receptor Agonists Price (US$/Unit) by Application (2020-2031)
 Figure 59. Melatonin Receptor Agonists Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS